Theres got to be more to this story
It is the most clinically studied GLP-1 medication for weight loss
By activating both GIP and GLP-1 receptors, tirzepatide enhances insulin secretion in response to elevated blood glucose levels, suppresses inappropriate glucagon release, slows gastric emptying, and reduces appetite through effects on brain centers that regulate food intake
Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
For patients seeking evidence-based weight management support, NICE-recommended options include structured lifestyle interventions, behavioural support programmes, and licensed pharmacotherapies such as orlistat or semaglutide where clinically appropriate
Diabetes Ther (2019) 10(5):177192